BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kojima H, Sakurai S, Uemura M, Fukui H, Morimoto H, Tamagawa Y. Mitochondrial Abnormality and Oxidative Stress in Nonalcoholic Steatohepatitis. Alcoholism Clin Exp Res 2007;31:S61-6. [DOI: 10.1111/j.1530-0277.2006.00288.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Front Pharmacol 2020;11:603926. [PMID: 33343375 DOI: 10.3389/fphar.2020.603926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
2 Pagadala M, Kasumov T, McCullough AJ, Zein NN, Kirwan JP. Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2012;23:365-371. [PMID: 22609053 DOI: 10.1016/j.tem.2012.04.005] [Cited by in Crossref: 182] [Cited by in F6Publishing: 161] [Article Influence: 20.2] [Reference Citation Analysis]
3 Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease: REVIEW: PAEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE. Alimentary Pharmacology & Therapeutics 2008;28:13-24. [DOI: 10.1111/j.1365-2036.2008.03703.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 6.8] [Reference Citation Analysis]
4 Yuan JM, Grouls M, Carmella SG, Wang R, Heskin A, Jiang Y, Tan YT, Adams-Haduch J, Gao YT, Hecht SS. Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma. Carcinogenesis 2019;40:989-97. [PMID: 30615102 DOI: 10.1093/carcin/bgy180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
5 Xu L, Wei Y, Dong D, Yin L, Qi Y, Han X, Xu Y, Zhao Y, Liu K, Peng J. iTRAQ-based proteomics for studying the effects of dioscin against nonalcoholic fatty liver disease in rats. RSC Adv 2014;4:30704. [DOI: 10.1039/c4ra03948c] [Cited by in Crossref: 32] [Article Influence: 4.6] [Reference Citation Analysis]
6 Kwon H, Song K, Han C, Chen W, Wang Y, Dash S, Lim K, Wu T. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease. Hepatology. 2016;63:1155-1169. [PMID: 26473743 DOI: 10.1002/hep.28289] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
7 Nan YM, Wu WJ, Fu N, Liang BL, Wang RQ, Li LX, Zhao SX, Zhao JM, Yu J. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scand J Gastroenterol. 2009;44:1121-1131. [PMID: 19606393 DOI: 10.1080/00365520903114912] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
8 Zhang NP, Liu XJ, Xie L, Shen XZ, Wu J. Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Lab Invest. 2019;99:749-763. [PMID: 30700851 DOI: 10.1038/s41374-018-0177-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 18.5] [Reference Citation Analysis]
9 Caldwell SH, de Freitas LAR, Park SH, Moreno MLV, Redick JA, Davis CA, Sisson BJ, Patrie JT, Cotrim H, Argo CK, Al-osaimi A. Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2009;49:1888-95. [DOI: 10.1002/hep.22851] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
10 Raso GM, Esposito E, Iacono A, Pacilio M, Cuzzocrea S, Canani RB, Calignano A, Meli R. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat. Eur J Pharmacol 2009;604:125-31. [PMID: 19135440 DOI: 10.1016/j.ejphar.2008.12.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wei J, Shi M, Wu WQ, Xu H, Wang T, Wang N, Ma JL, Wang YG. IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice. World J Gastroenterol. 2011;17:5203-5213. [PMID: 22215946 DOI: 10.3748/wjg.v17.i47.5203] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
12 Fealy CE, Haus JM, Solomon TP, Pagadala M, Flask CA, McCullough AJ, Kirwan JP. Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. J Appl Physiol (1985) 2012;113:1-6. [PMID: 22582214 DOI: 10.1152/japplphysiol.00127.2012] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
13 Li S, Wu WC, He CY, Han Z, Jin DY, Wang L. Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats. World J Gastroenterol 2008;14:3254-8. [PMID: 18506935 DOI: 10.3748/wjg.14.3254] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
14 Nichols TW. Mitochondria of mice and men: Moderate magnetic fields in obesity and fatty liver. Medical Hypotheses 2012;79:287-93. [DOI: 10.1016/j.mehy.2012.05.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schults MA, Nagle PW, Rensen SS, Godschalk RW, Munnia A, Peluso M, Claessen SM, Greve JW, Driessen A, Verdam FJ, Buurman WA, van Schooten FJ, Chiu RK. Decreased nucleotide excision repair in steatotic livers associates with myeloperoxidase-immunoreactivity. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2012;736:75-81. [DOI: 10.1016/j.mrfmmm.2011.11.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
16 Zoppini G, Cacciatori V, Negri C, Stoico V, Lippi G, Targher G, Bonora E. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine (Baltimore) 2016;95:e4821. [PMID: 27787357 DOI: 10.1097/MD.0000000000004821] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
17 Du M, Wang X, Yuan L, Liu B, Mao X, Huang D, Yang L, Huang K, Zhang F, Wang Y, Luo X, Wang C, Peng J, Liang M, Huang D, Huang K. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice. Journal of Hepatology 2020;73:1333-46. [DOI: 10.1016/j.jhep.2020.07.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 Lockman KA, Baren JP, Pemberton CJ, Baghdadi H, Burgess KE, Plevris-papaioannou N, Lee P, Howie F, Beckett G, Pryde A, Jaap AJ, Hayes PC, Filippi C, Plevris JN. Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis. Liver Int 2012;32:1079-92. [DOI: 10.1111/j.1478-3231.2012.02775.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
19 Patel R, Baker SS, Liu W, Desai S, Alkhouri R, Kozielski R, Mastrandrea L, Sarfraz A, Cai W, Vlassara H. Effect of dietary advanced glycation end products on mouse liver. PLoS One. 2012;7:e35143. [PMID: 22496902 DOI: 10.1371/journal.pone.0035143] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
20 Song BJ, Akbar M, Jo I, Hardwick JP, Abdelmegeed MA. Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease. Adv Pharmacol 2015;74:303-72. [PMID: 26233911 DOI: 10.1016/bs.apha.2015.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
21 Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz JM. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring) 2016;24:453-60. [PMID: 26499447 DOI: 10.1002/oby.21371] [Cited by in Crossref: 91] [Cited by in F6Publishing: 72] [Article Influence: 15.2] [Reference Citation Analysis]
22 Ferolla SM, Couto CA, Costa-Silva L, Armiliato GN, Pereira CA, Martins FS, Ferrari Mde L, Vilela EG, Torres HO, Cunha AS, Ferrari TC. Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. Nutrients 2016;8:E397. [PMID: 27367724 DOI: 10.3390/nu8070397] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
23 Kurinami N, Sugiyama S, Morita A, Yoshida A, Hieshima K, Miyamoto F, Kajiwara K, Jinnouch K, Jinnouchi T, Jinnouchi H. Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2018;139:122-30. [DOI: 10.1016/j.diabres.2018.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Gao Y, Wang Y, Liu H, Liu Z, Zhao J. Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis. Dig Liver Dis 2020;52:637-43. [PMID: 32360132 DOI: 10.1016/j.dld.2020.03.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr. 2009;139:905-911. [PMID: 19321579 DOI: 10.3945/jn.108.101808] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 12.4] [Reference Citation Analysis]
26 Yuan Y, Naito H, Jia X, Kitamori K, Nakajima T. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways. Nutrients 2017;9:E1018. [PMID: 28906458 DOI: 10.3390/nu9091018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
27 Hasan MK, Friedman TC, Sims C, Lee DL, Espinoza-Derout J, Ume A, Chalfant V, Lee ML, Sinha-Hikim I, Lutfy K, Liu Y, Mahata SK, Sinha-Hikim AP. α7-Nicotinic Acetylcholine Receptor Agonist Ameliorates Nicotine Plus High-Fat Diet-Induced Hepatic Steatosis in Male Mice by Inhibiting Oxidative Stress and Stimulating AMPK Signaling. Endocrinology 2018;159:931-44. [PMID: 29272360 DOI: 10.1210/en.2017-00594] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
28 Kelishadi R, Farajian S, Mirlohi M. Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences. Hepat Mon 2013;13:e7233. [PMID: 23885277 DOI: 10.5812/hepatmon.7233] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
29 Desai S, Baker SS, Liu W, Moya DA, Browne RW, Mastrandrea L, Baker RD, Zhu L. Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis. Liver Int 2014;34:110-7. [PMID: 24028323 DOI: 10.1111/liv.12308] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
30 Liu B, Yi W, Mao X, Yang L, Rao C. Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis. Am J Physiol Endocrinol Metab 2021;320:E925-37. [PMID: 33813878 DOI: 10.1152/ajpendo.00614.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Leghi GE, Domenici FA, Vannucchi H. INFLUENCE OF OXIDATIVE STRESS AND OBESITY IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS. Arq Gastroenterol 2015;52:228-33. [DOI: 10.1590/s0004-28032015000300014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Friedman TC, Sinha-Hikim I, Parveen M, Najjar SM, Liu Y, Mangubat M, Shin CS, Lyzlov A, Ivey R, Shaheen M, French SW, Sinha-Hikim AP. Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice. Endocrinology 2012;153:5809-20. [PMID: 23093702 DOI: 10.1210/en.2012-1750] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
33 van 't Erve TJ, Kadiiska MB, London SJ, Mason RP. Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis. Redox Biol 2017;12:582-99. [PMID: 28391180 DOI: 10.1016/j.redox.2017.03.024] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 19.3] [Reference Citation Analysis]
34 Syn WK, Yang L, Chiang DJ, Qian Y, Jung Y, Karaca G, Choi SS, Witek RP, Omenetti A, Pereira TA, Diehl AM. Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. Liver Int 2009;29:1262-72. [PMID: 19490416 DOI: 10.1111/j.1478-3231.2009.02036.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
35 Ferolla SM, Armiliato GN, Couto CA, Ferrari TC. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World J Hepatol. 2015;7:559-565. [PMID: 25848479 DOI: 10.4254/wjh.v7.i3.559] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
36 Hasan KM, Friedman TC, Shao X, Parveen M, Sims C, Lee DL, Espinoza-Derout J, Sinha-Hikim I, Sinha-Hikim AP. E-cigarettes and Western Diet: Important Metabolic Risk Factors for Hepatic Diseases. Hepatology 2019;69:2442-54. [PMID: 30664268 DOI: 10.1002/hep.30512] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
37 Abdelmegeed MA, Ha SK, Choi Y, Akbar M, Song BJ. Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances. Curr Mol Pharmacol 2017;10:207-25. [PMID: 26278393 DOI: 10.2174/1874467208666150817111114] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 17.5] [Reference Citation Analysis]
38 Klein MS, Dorn C, Saugspier M, Hellerbrand C, Oefner PJ, Gronwald W. Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy. Metabolomics 2011;7:237-46. [DOI: 10.1007/s11306-010-0243-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Ling J, Chaba T, Zhu LF, Jacobs RL, Vance DE. Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice. Hepatology 2012;55:1094-102. [PMID: 22095799 DOI: 10.1002/hep.24782] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
40 Hiramitsu M, Shimada Y, Kuroyanagi J, Inoue T, Katagiri T, Zang L, Nishimura Y, Nishimura N, Tanaka T. Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis. Sci Rep 2014;4:3708. [PMID: 24424211 DOI: 10.1038/srep03708] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
41 Ivey R, Desai M, Green K, Sinha-Hikim I, Friedman TC, Sinha-Hikim AP. Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling. Horm Metab Res 2014;46:568-73. [PMID: 24830635 DOI: 10.1055/s-0034-1375610] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
42 Koek G, Liedorp P, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clinica Chimica Acta 2011;412:1297-305. [DOI: 10.1016/j.cca.2011.04.013] [Cited by in Crossref: 202] [Cited by in F6Publishing: 176] [Article Influence: 20.2] [Reference Citation Analysis]
43 Sodhi K, Bracero L, Feyh A, Nichols A, Srikanthan K, Latif T, Preston D, Shapiro JI, Elitsur Y. Role of Serum Biomarkers in Early Detection of Non-Alcoholic Steatohepatitis and Fibrosis in West Virginian Children. J Clin Cell Immunol 2016;7:393. [PMID: 27182456 DOI: 10.4172/2155-9899.1000393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
44 Ji G, Yang Q, Hao J, Guo L, Chen X, Hu J, Leng L, Jiang Z. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int Immunopharmacol. 2011;11:762-768. [PMID: 21320636 DOI: 10.1016/j.intimp.2011.01.036] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 7.2] [Reference Citation Analysis]
45 Sinha-Hikim AP, Sinha-Hikim I, Friedman TC. Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights. Front Endocrinol (Lausanne) 2017;8:23. [PMID: 28239368 DOI: 10.3389/fendo.2017.00023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
46 Zhu MJ, Sun LJ, Liu YQ, Feng YL, Tong HT, Hu YH, Zhao Z. Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis. World J Gastroenterol 2008;14:4677-83. [PMID: 18698683 DOI: 10.3748/wjg.14.4677] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
47 Sinha-Hikim I, Sinha-Hikim AP, Shen R, Kim HJ, French SW, Vaziri ND, Crum AC, Rajavashisth TB, Norris KC. A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. Exp Mol Pathol 2011;91:419-28. [PMID: 21570964 DOI: 10.1016/j.yexmp.2011.04.009] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
48 Wang JQ, Zou YH, Huang C, Lu C, Zhang L, Jin Y, Lü XW, Liu LP, Li J. Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats. Acta Pharmacol Sin 2012;33:791-7. [PMID: 22543705 DOI: 10.1038/aps.2012.19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]